[go: up one dir, main page]

KR890009385A - 피막 형성성 항진균제 조성물 - Google Patents

피막 형성성 항진균제 조성물 Download PDF

Info

Publication number
KR890009385A
KR890009385A KR1019880016351A KR880016351A KR890009385A KR 890009385 A KR890009385 A KR 890009385A KR 1019880016351 A KR1019880016351 A KR 1019880016351A KR 880016351 A KR880016351 A KR 880016351A KR 890009385 A KR890009385 A KR 890009385A
Authority
KR
South Korea
Prior art keywords
antifungal composition
acid ester
film forming
encapsulating
fatty acid
Prior art date
Application number
KR1019880016351A
Other languages
English (en)
Other versions
KR970001701B1 (ko
Inventor
이즈미 사이또
가오리 이께다
요시오 도이
쇼헤이 에가와
Original Assignee
요오또시 가즈오
시오노기세이야꾸 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 요오또시 가즈오, 시오노기세이야꾸 가부시끼가이샤 filed Critical 요오또시 가즈오
Publication of KR890009385A publication Critical patent/KR890009385A/ko
Application granted granted Critical
Publication of KR970001701B1 publication Critical patent/KR970001701B1/ko

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015Drug-containing film-forming compositions, e.g. spray-on
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

내용 없음

Description

피막 형성성 항진균제 조성물
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
종축은 피부내 TOL양을 나타내는 반면, 횡축은 시간을 나타낸다.
피부내 TOL 잔류량은 대조군에 대해서 “●”표로 실시예 1의 조성물에 대해서는 “○”표로 나타낸다.

Claims (5)

  1. 알콕시 용매중에 약 0.1% 내지 약 1.5%의 톨나프테이트, 약 10% 내지 약 20%의 디메틸아미노에틸 메탈크릴레이트-메타크릴산 에스테르 공중합체 및 0.5% 내지 약 10%의 중간 사슬 지방산 에스테르를 필수적으로 함유하지만 실제로 물을 함유하진 않는 피막형성성 항진균제 조성물.
  2. 제1항에 있어서, 중간 사슬지방산 에스테르가 테트라 글리세릴 모노카프레이트이 피막 형성성 항진균제 조성물.
  3. 제1항에 있어서, 약 0.1% 내지 약5%의 농화제를 더 함유하는 피막 형성성항진균제 조성물.
  4. 제1항에 있어서, 상기 알콜성 용매가 에탄올 또는 이소프로판올인 피막 형성성 항진균데 조성물.
  5. 제3항에 있어서, 농화제가 에틸셀로스, 히드록시프로필 셀룰로스 또는 히드록시프로필메틸셀룰로스인 피막형성성 항진균제 조성물.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019880016351A 1987-12-08 1988-12-08 피막 형성성 항진균제 조성물 KR970001701B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP62310480A JPH07116035B2 (ja) 1987-12-08 1987-12-08 被膜形成性抗真菌剤組成物
JP310480/1987 1987-12-08

Publications (2)

Publication Number Publication Date
KR890009385A true KR890009385A (ko) 1989-08-01
KR970001701B1 KR970001701B1 (ko) 1997-02-14

Family

ID=18005744

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019880016351A KR970001701B1 (ko) 1987-12-08 1988-12-08 피막 형성성 항진균제 조성물

Country Status (8)

Country Link
US (1) US4915940A (ko)
EP (1) EP0319964B1 (ko)
JP (1) JPH07116035B2 (ko)
KR (1) KR970001701B1 (ko)
AT (1) ATE73675T1 (ko)
DE (1) DE3869355D1 (ko)
ES (1) ES2032323T3 (ko)
GR (1) GR3004551T3 (ko)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5116603A (en) * 1989-01-31 1992-05-26 Yissum Research Development Company Of The Hebrew University Of Jerusalem Oral antifungal preventative, and method of use
US5026554A (en) * 1990-09-13 1991-06-25 Merck & Co., Inc. Method of inhibiting fungal growth using squalene synthetase inhibitors
SK43294A3 (en) * 1991-10-16 1995-01-12 Richardson Vicks Inc Agent improving the penetration of treatments at surface application
ATE133560T1 (de) * 1991-10-16 1996-02-15 Richardson Vicks Inc Wässeriges,kosmetisches gel,mit niedrigem ph,das nichtionogene polyacrylamidderivate enthält
EG20380A (en) * 1991-10-16 1999-02-28 Richardson Vicks Inc Enhanced skin penetration system for improved topical delivery of drugs
JP3567990B2 (ja) * 1992-07-28 2004-09-22 ザ、プロクター、エンド、ギャンブル、カンパニー 架橋陽イオン重合体とアルコキシ化エーテルとを含有する局所用途用医薬組成物
US5989536A (en) * 1993-07-03 1999-11-23 The Procter & Gamble Company Personal cleansing compositions containing alkoxylated ether and cationic ammonium salt for deposition of active agent upon the skin
CA2188566A1 (en) * 1994-05-05 1995-11-16 Conrad Winters Topical polymeric drug delivery system
FR2732223B1 (fr) * 1995-03-30 1997-06-13 Sanofi Sa Composition pharmaceutique pour administration transdermique
JP2001505532A (ja) 1996-06-24 2001-04-24 バイオ―セイフ エンタープライジズ,インコーポレイテッド 抗菌性組成物
US5955097A (en) * 1996-10-18 1999-09-21 Virotex Corporation Pharmaceutical preparation applicable to mucosal surfaces and body tissues
US20030143189A1 (en) * 2001-11-14 2003-07-31 Askill Ian N Therapy for topical diseases
AU2002950506A0 (en) * 2002-07-31 2002-09-12 Soltec Research Pty Ltd Percutaneous delivery system
JP5059408B2 (ja) * 2004-08-05 2012-10-24 久光製薬株式会社 爪用外用剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1186691A (en) * 1967-03-30 1970-04-02 Edward Henderson Antiseptic Compositions
US4136162A (en) * 1974-07-05 1979-01-23 Schering Aktiengesellschaft Medicament carriers in the form of film having active substance incorporated therein
US3989815A (en) * 1975-06-19 1976-11-02 Nelson Research & Development Company Novel N-bis-azacyclopentan-2-onyl alkanes
DE2920500A1 (de) * 1979-05-21 1980-11-27 Boehringer Sohn Ingelheim Pharmazeutische zubereitung in form eines polyacrylatfilmes
JPH08159425A (ja) * 1994-12-08 1996-06-21 Wataru Momose 溶融炉

Also Published As

Publication number Publication date
KR970001701B1 (ko) 1997-02-14
GR3004551T3 (ko) 1993-04-28
JPH07116035B2 (ja) 1995-12-13
EP0319964B1 (en) 1992-03-18
JPH01149722A (ja) 1989-06-12
DE3869355D1 (de) 1992-04-23
ES2032323T3 (es) 1993-02-01
EP0319964A1 (en) 1989-06-14
US4915940A (en) 1990-04-10
ATE73675T1 (de) 1992-04-15

Similar Documents

Publication Publication Date Title
KR890009385A (ko) 피막 형성성 항진균제 조성물
KR890004689A (ko) 니트로글리세린 스프레이
KR950002750A (ko) 살정자성 및 항바이러스성 윤활제 조성물 및 이의 사용방법
KR890014104A (ko) 심장과 심맥관계에 특히 작용하는 약학적 조성과 이의 제조방법 공정
KR830000911A (ko) X-선 콘트라스트제제의 살균된 주사용의 생리적으로 가능한 용액의 제조방법 및 x-선콘트라스트 제제 및 완충액
HUT77631A (hu) Eljárás a levobupivakain és származékai rezolválására
KR940013497A (ko) 소염진통겔 제제
KR970061246A (ko) 테스토스테론을 증가시키기 위한 약학 조성물
KR880013557A (ko) 신규 안과용 조성물
KR890009391A (ko) 무좀 치료제
KR890013520A (ko) 네가형 감광성 수지 조성물
KR890003882A (ko) 개선된 가공 안정성을 갖는 내자외선성 카보네이트 중합체 및 그의 제조방법
KR890009388A (ko) 비타민 e 배합 외용제
KR890701584A (ko) 20, 21-디노르에비나메닌의 신규 치환 유도체, 그의 제조 방법 및 이 방법으로 얻는 신규 중간체, 약제로서의 그의 용도 및 그를 함유하는 제약 조성물
GB1310140A (en) Hair setting and fixing agent
KR970032514A (ko) 솔 식초 및 이를 함유하는 음료 조성물
KR900000455A (ko) 자외선을 흡수하는 시클로헥센일리덴 조성물
GB1382427A (en) Composition and method for strengthening nails
KR960006929A (ko) 좀담배풀 추출물을 유효성분으로 하는 갑상선 질환 치료용 약제
KR860000018A (ko) 감의 코오팅 처리방법
KR920011492A (ko) 시플로플록사신의 주사용 조성물 및 그 제조방법
KR950007838A (ko) 은행잎 엑기스 연질캅셀제 및 그의 제조방법
ATE19077T1 (de) Thiophen-derivat mit mucoregulatorischer und anti-husten-wirkung, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zusammensetzungen.
KR970032513A (ko) 알로에 식초 및 이를 함유하는 음료 조성물
KR830003908A (ko) 코티코스테로이드 물질을 함유하는 약학조성물

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19881208

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19930803

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19881208

Comment text: Patent Application

G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

Comment text: Decision on Publication of Application

Patent event code: PG16051S01I

Patent event date: 19970120

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 19970428

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 19970716

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 19970716

End annual number: 3

Start annual number: 1

PR1001 Payment of annual fee

Payment date: 19991206

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20010507

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20020514

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 20030529

Start annual number: 7

End annual number: 7

FPAY Annual fee payment

Payment date: 20040709

Year of fee payment: 8

PR1001 Payment of annual fee

Payment date: 20040709

Start annual number: 8

End annual number: 8

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee